Ignite Creation Date:
2024-05-06 @ 3:34 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04678518
Status:
UNKNOWN
Last Update Posted:
2022-05-19
First Post:
2020-10-20
Brief Title:
Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation
Sponsor:
Hamad Medical Corporation
Organization:
Hamad Medical Corporation
Study Overview
Official Title:
Inflammatory Markers Dynamics in Response to Extra-corporeal Membrane Oxygenator Decannulation
Status:
UNKNOWN
Status Verified Date:
2022-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ECMO
Brief Summary:
Extracorporeal membrane oxygenation ECMO aim at providing cardiac respiratory support or both The use of ECMO could be associated with systemic inflammatory response syndrome SIRS at the time of initiation or the time of decannulation There is an existing evidence to state that clinical criteria of SIRS accompany decannulation We aim at proving this relation through studying the inflammatory markers changes before and after decannulation The investigators will study all participants who require ECMO support in the heart hospital all patient will be subjected to clinical evaluation of the SIRS criteria plus studying the inflammatory makers that will include IL1 IL2 IL6 and TNF before and after decannulation Participants will be divided based on the SIRS criteria into 2 groups and both groups will be compared using Chi-Square analysis Fisher tests if small sample size or two tailed t-test as appropriate
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None